# OnCo record netter-1 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/netter-1/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "netter-1", "NCT01578239" ;
  schema:name "NETTER-1"@en ;
  schema:description "The trial that made radioligand therapy a standard: a radioactive drug homing to the somatostatin receptor held midgut neuroendocrine tumours in check far longer than high-dose octreotide, and it underpins Lutathera's approvals."@en ;
  schema:url <https://onco.cc/trials/netter-1/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01578239>, <https://doi.org/10.1056/NEJMoa1607427> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2012-09-06" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/small-intestinal-net/> ;
  onco:technologies <https://onco.cc/technologies/prrt/> ;
  onco:targets <https://onco.cc/targets/sstr2/> ;
  onco:drugs <https://onco.cc/drugs/lutathera/>, <https://onco.cc/drugs/octreotide-lanreotide/> ;
  onco:companies <https://onco.cc/companies/novartis/> .